MAP2K7 and colonic neoplasm: Wild-type PIK3CA colon cancer cells displayed sensitivity to each of the MEK inhibitors; however, the mutant PIK3CA colon cancer cells did not respond to the MEK inhibitors (Fig. 1a and Supplementary Table S1).